This learning programme has been designed to introduce you to genomics and pharmacogenomics, and to highlight the opportunities they can bring to the provision of person-centred care in your area of practice. It will also allow you to explore the application of genomics and pharmacogenomics in the larger healthcare context.
2h:00m (for events this includes pre and post event learning)
Learning Objectives:On completion of all aspects of this learning programme you should be able to:
Study time: 30 minutes
Why take this course?
As genomics moves out of specialist services and into the mainstream, it is likely to be encountered by more healthcare professionals than ever before, including those who are engaging with this technology for the first time. This course is designed to give an overview of how genomics can be used in a variety of clinical scenarios.
Who is this course aimed at?
The content of the course is aimed at those healthcare professionals who have had limited or no exposure to genomics in their clinical roles. The course would also be suitable for those looking to refresh their knowledge or support training.
What will I learn?
The course covers the following topics:- Is genomics relevant to me?
This e-assessment is linked with the CPPE Introduction to genomics in pharmacy e-learning programme and assesses you on the learning objectives in that programme.
Why should I do this assessment?This e-assessment completes the learning you began with the CPPE Introduction to genomics in pharmacy e-learning programme. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a CPD entry on the learning. It may also provide evidence for achieving competencies in the RPS Foundation or Advanced Pharmacy Frameworks.
The National Genomic Test Directory outlines the full range of genomic tests that are commissioned for the NHS in England, the technology by which they are available, and the patients who are eligible to access a test. You can also find information on how the test directory was created and is updated via this link.
This report, jointly authored by Royal College of Physicians and British Pharmacological Society, explores pharmacogenomics in the NHS and offers a perspective on how pharmacogenomics in the UK may develop over time. The report lists a series of recommendations, but it is not a policy document.
The government strategy for genomics in the UK, published in 2020, sets out ambitions for the next ten years. It includes sections on diagnosis and personalised medicine, prevention, research, patient and public engagement, workforce development, data and analytics, industry and regulation.
Please help us improve our website by letting us know what you like and reporting anything that isn't quite right.